Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions

Kidney International

Volumn 69, Issue 1, 2006, Pages 144-151

  Ujhelyi, L ^a   Balla, G ^a   Jeney, V ^a   Varga, Z ^a   Nagy, E ^a   Vercellotti, G M ^b   Agarwal, A ^c   Eaton, J W ^d   Balla, J ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Endothelial cell injury; Ferritin; Heme oxygenase; Hemodialysis; LDL oxidation; Uremic retention solutes

Indexed keywords

ASCORBIC ACID; BILIRUBIN; CRESOL; FERRITIN; HEME OXYGENASE 1; INDICAN; LOW DENSITY LIPOPROTEIN; PHENOL; URIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROTECTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENDOTHELIUM INJURY; HEMODIALYSIS; HUMAN; KIDNEY EPITHELIUM; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; ULTRAFILTRATION; UPREGULATION; UREMIA;

ADULT; AGED; ANTIOXIDANTS; ATHEROSCLEROSIS; CYTOPROTECTION; ENDOTHELIAL CELLS; FEMALE; FERRITINS; HEME OXYGENASE-1; HEPARIN; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RENAL DIALYSIS; RNA, MESSENGER; ULTRAFILTRATION;

EID: 30944446633     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000007     Document Type: Article

References (53)

1. Steinberg D, Parthasarathy S, Carew TE et al. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
2. Balla G, Jacob HS, Eaton JW et al. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial cell injury. Arterioscler Thromb 1991; 11: 1700-1711.
3. Jeney V, Balla J, Yachie A et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100: 879-887.
4. Miller YI, Altamentova SM, Shaklai N. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: Antioxidant role of haptoglobin. Biochemistry 1997; 36: 12189-12198.
5. Ziouzenkova O, Asatryan L, Akmal M et al. Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis. J Biol Chem 1999; 274: 18916-18924.
6. Hennig B, Chow CK. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med 1988; 4: 99-105.
7. Balla G, Jacob HS, Balla J et al. A cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992; 267: 18148-18153.
8. Balla J, Jacob HS, Balla G et al. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 1993; 90: 9285-9289.
9. Agarwal A, Balla J, Balla G et al. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 1996; 271: 814-823.
10. Abraham NG, Lavrovsky Y, Schwartzman ML et al. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA 1995; 92: 6798-6802.
11. Maines MD, Kappas A. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc Natl Acad Sci USA 1974; 71: 4293-4297.
12. Keyse SM, Tyrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblast by UVA radiation, hydrogen peroxide, and sodium arsenate. Proc Natl Acad Sci USA 1989; 86: 99-103.
13. Choi AM, Otterbein LE. Emerging role of carbon monoxide in physiologic and pathophysiologic states. Antioxid Redox Signal 2002; 4: 227-238.
14. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161-203.
15. Juckett MB, Balla J, Balla G et al. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 1995; 147: 782-789.
16. Wang LJ, Lee TS, Lee FY et al. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998; 152: 711-720.
17. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 1992; 286: 901-905.
18. Mailloux LU, Bellucci AG, Wilkes BM et al. Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis 1991; 18: 326-335.
19. Maher ER, Wickens DG, Griffin JF et al. Increased free-radical activity during haemodialysis? Nephrol Dial Transplant 1987; 2: 169-171.
20. Usberti M, Gerardi GM, Gazzotti RM et al. Oxidative stress and cardiovascular disease in dialyzed patients. Nephron 2002; 91: 25-33.
21. Drüeke TB, Nguyen-Khoa T, Massy ZA et al. Role of oxidized low-density lipoprotein in the atherosclerosis of uraemia. Kidney Int 2001; 78: S114-S119.
22. Bayes B, Pastor MC, Bonal J et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 106-112.
23. Maggi E, Bellazzi R, Gazo A et al. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 1994; 46: 869-876.
24. Van Tits L, De Graaf J, Hak-Lemmers H et al. Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Invest 2003; 83: 13-21.
25. Westhuyzen J, Saltissi D, Healy H. Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls. Atherosclerosis 1997; 129: 199-205.
26. Sutherland WH, Walker RJ, Ball MJ et al. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 1995; 48: 227-236.
27. Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213-1218.
28. Galli F, Varga Zs, Balla J et al. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 2001; 78: S148-S154.
29. Triolo L, Malaguti M, Ansali F et al. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients. Artif Cells Blood Substit Immobil Biotechnol 2003; 31: 185-191.
30. Islam KN, O'Byrne D, Devaraj S et al. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 2000; 150: 217-224.
31. HultQvist M, Hegbrant J, Nilsson-Thorell C et al. Plasma concentration of vitamin C, vitamin E and/or malondialdehydeas markers of oxygen free radical production during hemodialysis. Clin Nephrol 1997; 47: 37-46.
32. Balla J, Vercellotti GM, Nath K et al. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 2003; 18(Suppl 5): 8-12.
33. Tomura S, Nakamura Y, Deguchi F et al. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy. Thromb Res 1990; 58: 413-419.
34. Takagi M, Wada H, Mukai K et al. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis. Blood Coagul Fibrinolysis 1994; 5: 713-717.
35. Jacobson SH, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002; 22: 42-47.
36. Patterson RA, Horsley ET, Leake DS. Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J Lipid Res 2003; 44: 512-521.
37. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V et al. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int 1999; 56: 747-753.
38. Gerardi G, Usberti M, Martini G et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002; 40: 104-110.
39. Ujhelyi L, Balla J, Muszbek L et al. A microassay to assess the oxidative resistance of low-density lipoprotein. Clin Chem 1998; 44: 1762-1764.
40. Niwa T. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection. Clin Chem 1993; 39: 106-111.
41. Agatsuma S, Sekino H, Watanabe H. Indoxyl-β-D-glucuronide and 3-indoxyl sulphate in plasma of hemodialysis patients. Clin Nephrol 1996; 45: 250-256.
42. Yeung SY, Lan WH, Huang CS et al. Scavenging property of three cresol isomers against H2O2, hypochlorite, superoxide and hydroxyl radicals. Food Chem Toxicol 2002; 40: 1403-1413.
43. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943.
44. Van Lenten BJ, Prieve J, Navab M et al. Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo. J Clin Invest 1995; 95: 2104-2110.
45. Ewing JF, Haber SN, Maines MD. Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. J Neurochem 1992; 58: 1140-1149.
46. Dore S, Takahashi M, Ferris CD et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999; 96: 2445-2450.
47. Motterlini R, Mann BE, Johnson TR et al. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 2003; 30: 2525-2539.
48. Nath KA, Balla G, Vercellotti GM et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-270.
49. Agarwal A, Kim Y, Matas AJ et al. Gas-generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation 1996; 61: 93-98.
50. Sato K, Balla J, Otterbein L et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. Immunol 2001; 166: 4185-4194.
51. Yachie A, Niida Y, Wada T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-135.
52. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997; 94: 10919-10924.
53. Andrew D, Rule MD, Timothy S et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 637-929.